SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001044321-07-000114
Filing Date
2007-02-22
Accepted
2007-02-22 16:59:38
Documents
1
Period of Report
2007-02-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5836
  Complete submission text file 0001044321-07-000114.txt   7959
Mailing Address 501 SECOND STREET SUITE 211 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET SUITE 211 SAN FRANCISCO CA 94107 415-543-3470
MEDIVATION, INC. (Issuer) CIK: 0001011835 (see all company filings)

IRS No.: 133863260 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Reporting) CIK: 0001044321 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32836 | Film No.: 07642920